{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T20:19:38Z","timestamp":1649189978980},"reference-count":93,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.pcl.2004.11.004","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T10:53:11Z","timestamp":1113821591000},"page":"97-134","source":"Crossref","is-referenced-by-count":2,"title":["Anxiety and Depressive Disorders in College Youth"],"prefix":"10.1016","volume":"52","author":[{"given":"Swati","family":"Bhave","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitendra","family":"Nagpal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcl.2004.11.004_bib1","series-title":"Child and adolescent psychiatry. Mosby's neurology psychiatry access series","author":"Parmelee Dean","year":"1996"},{"key":"10.1016\/j.pcl.2004.11.004_bib2","first-page":"14","article-title":"Issues in the use of benzodiazepine therapy","volume":"53","author":"Roth","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib3","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF00178503","article-title":"Chronic use of benzodiazepines and psychomotor and cognitive test performance","volume":"88","author":"Lucki","year":"1986","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pcl.2004.11.004_bib4","series-title":"Benzodiazepine dependence, toxicity and abuse: a task force report of the American Psychiatric Association","year":"1990"},{"key":"10.1016\/j.pcl.2004.11.004_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00004714-199204000-00002","article-title":"Comparative drug effects and abuse liability of lorazepam, buspirone, and secobarbital in nondependent subjects","volume":"12","author":"Sellers","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pcl.2004.11.004_bib6","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1056\/NEJM198610023151403","article-title":"Withdrawal reactions after long-term therapeutic use of benzodiazepines","volume":"315","author":"Busto","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcl.2004.11.004_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-1017439","article-title":"Withdrawal phenomena after long-term administration of benzodiazepines: a review of recent investigations","volume":"16","author":"Schopf","year":"1983","journal-title":"Pharmacopsychiatrie Neuro- Psychopharmakologie"},{"key":"10.1016\/j.pcl.2004.11.004_bib8","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0140-6736(83)92355-3","article-title":"Gradual withdrawal of diazepam after long-term therapy","volume":"1","author":"Tyrer","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.pcl.2004.11.004_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0740-5472(91)90023-4","article-title":"Protracted withdrawal syndromes from benzodiazepines","volume":"8","author":"Ashton","year":"1991","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.pcl.2004.11.004_bib10","first-page":"382","article-title":"Benzodiazepine withdrawal: a review of evidence","volume":"49","author":"Noyes","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib11","first-page":"344","article-title":"Alprazolam withdrawal delirium unresponsive to diazepam: case report","volume":"46","author":"Zipursky","year":"1985","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib12","series-title":"Textbook of clinical psychiatry","article-title":"Pharmacology and electro convulsive therapy","author":"Marangell","year":"2003"},{"key":"10.1016\/j.pcl.2004.11.004_bib13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2044.1984.tb07281.x","article-title":"Sedation for local anaesthesia: comparison of intravenous midazolam and diazepam","volume":"39","author":"Dixon","year":"1984","journal-title":"Anaesthesia"},{"key":"10.1016\/j.pcl.2004.11.004_bib14","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1213\/00000539-198609000-00004","article-title":"Comparison of psychomotor skills and amnesia after induction of anesthesia with midazolam or thiopental","volume":"65","author":"Reitan","year":"1986","journal-title":"Anesth Analg"},{"key":"10.1016\/j.pcl.2004.11.004_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0196-0644(05)81219-3","article-title":"Flumazenil: a new benzodiazepine antagonist","volume":"20","author":"Votey","year":"1991","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.pcl.2004.11.004_bib16","first-page":"409","article-title":"Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study","volume":"47","author":"Cohn","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib17","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1176\/ajp.136.9.1184","article-title":"The comparative efficacy of buspirone and diazepam in the treatment of anxiety","volume":"136","author":"Goldberg","year":"1979","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00004714-199002000-00002","article-title":"Is buspirone effective for panic disorder?","volume":"10","author":"Sheehan","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pcl.2004.11.004_bib19","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1176\/ajp.146.7.914","article-title":"Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder","volume":"146","author":"Gastfried","year":"1989","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/10401239509149042","article-title":"Augmentation with buspirone: a review","volume":"7","author":"Harvey","year":"1995","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib21","first-page":"569","article-title":"Issues in the monopharmacotherapy and polypharmacotherapy of obsessive-compulsive disorder","volume":"32","author":"Laird","year":"1996","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pcl.2004.11.004_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0887-6185(91)90019-P","article-title":"A pilot study of buspirone in the treatment o social phobia","volume":"5","author":"Munjack","year":"1991","journal-title":"J Anxiety Disorder"},{"key":"10.1016\/j.pcl.2004.11.004_bib23","first-page":"251","article-title":"Buspirone in social phobia","volume":"13","author":"Schneier","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pcl.2004.11.004_bib24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00007611-199002000-00014","article-title":"Long-term buspirone therapy for chronic anxiety: a multicenter international study to determine safety","volume":"83","author":"Rakel","year":"1990","journal-title":"South Med J"},{"key":"10.1016\/j.pcl.2004.11.004_bib25","first-page":"45","article-title":"Effects of chronically administered buspirone and diazepam on driving-related skills and performance","volume":"43","author":"Moskowitz","year":"1982","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib26","first-page":"69","article-title":"Assessment of the abuse liability of buspirone in recreational sedative users","volume":"43","author":"Cole","year":"1982","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM198308183090705","article-title":"Drug therapy: current status of benzodiazepines","volume":"309","author":"Greenblatt","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcl.2004.11.004_bib28","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jama.1983.03340060045024","article-title":"Long-term diazepam therapy and clinical outcome","volume":"250","author":"Rickels","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.pcl.2004.11.004_bib29","first-page":"293","article-title":"Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic vs psychic symptoms","volume":"49","author":"Hoehn-Saric","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/archpsyc.1986.01800010081010","article-title":"Imipramine and chlordiazepoxide in depressive and anxiety disorders: efficacy in anxious outpatients","volume":"43","author":"Kahn","year":"1986","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib31","first-page":"22","article-title":"Anxiety symptom relief in depression treatment outcomes","volume":"56","author":"Keller","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib32","first-page":"238","article-title":"Treatment of panic disorder and agoraphobia with clonazepam","volume":"47","author":"Spier","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib33","first-page":"4","article-title":"High-potency benzodiazepines for short-term management of panic disorder: the US evidence","volume":"15","author":"Tesar","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/archpsyc.1987.01800160093011","article-title":"Panic and avoidance in agoraphobia; application of path analysis of treatment studies","volume":"44","author":"Klein","year":"1987","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archpsyc.1983.01790020019002","article-title":"Treatment of phobias: comparison of imipramine and placebo","volume":"40","author":"Zitrin","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archpsyc.1980.01780140053006","article-title":"Treatment of endogenous anxiety with phobic, hysterical, and hypochondrial symptoms","volume":"39","author":"Sheehan","year":"1980","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF02244898","article-title":"MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine: a double blind-blind placebo controlled study","volume":"112","author":"van Vlient","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pcl.2004.11.004_bib38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF02190409","article-title":"Recent developments in the psychopharmacology of social phobia","volume":"244","author":"den Boer","year":"1995","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pcl.2004.11.004_bib39","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1192\/bjp.167.3.374","article-title":"Paroxetine in the treatment of panic disorder: a randomized, double-blind, placebo-controlled study","volume":"167","author":"Oehrberg","year":"1995","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004714-199004000-00007","article-title":"Fluoxetine in panic disorder","volume":"10","author":"Schenier","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pcl.2004.11.004_bib41","series-title":"Selective serotonin reuptake inhibitors: novel or commonplace agents?","first-page":"84","article-title":"Clinical and biochemical effects of selective serotonin-uptake inhibitors in anxiety disorders","author":"Westenberg","year":"1988"},{"key":"10.1016\/j.pcl.2004.11.004_bib42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00004714-199208000-00022","article-title":"Fluoxetine for the treatment of social phobia [letter]","volume":"12","author":"Black","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pcl.2004.11.004_bib43","first-page":"27","article-title":"Fluoxetine efficacy in social phobia","volume":"54","author":"Van Ameringen","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/s-2007-1021803","article-title":"New findings in the treatment of panic disorder","volume":"26","author":"Westernberg","year":"1993","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib45","first-page":"252","article-title":"Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol","volume":"49","author":"Liebowitz","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib46","first-page":"33","article-title":"Medication therapy for social phobia","volume":"55","author":"Marshall","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib47","first-page":"16","article-title":"Long-term treatment of social phobia with clonazepam","volume":"52","author":"Davidson","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib48","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archpsyc.1991.01810340070009","article-title":"Cognitive-behavioural and pharmacologic treatment for social phobia: a preliminary study","volume":"48","author":"Gelernter","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib49","first-page":"18","article-title":"Social phobia: a pharmacologic treatment overview","volume":"56","author":"Jefferson","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib50","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2125.1985.tb02714.x","article-title":"The effect of acute beta-adrenoceptor blockade on examination performance","volume":"19","author":"Drew","year":"1985","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pcl.2004.11.004_bib51","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1192\/bjp.142.5.512","article-title":"The effect of beta-adrenergic blocking drugs on speakers' performance and memory","volume":"142","author":"Hertely","year":"1983","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib52","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0002-9343(82)90592-7","article-title":"Effect of beta blockade and beta stimulation on stage fright","volume":"72","author":"Brantigan","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.pcl.2004.11.004_bib53","first-page":"8","article-title":"Beta-blockers in the treatment of performance anxiety","volume":"4","author":"Yudofsky","year":"1987","journal-title":"Harvard Mental Health Letter"},{"key":"10.1016\/j.pcl.2004.11.004_bib54","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/archpsyc.1991.01810320054008","article-title":"Clomipramine in the treatment of patients with obsessive\u2013compulsive disorder","volume":"48","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib55","first-page":"301","article-title":"Fluvoxamine versus clomipramine in the treatment of obsessive-compulsive disorder: a multi-center, randomized, double-blind parallel group","volume":"55","author":"Freeman","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib56","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archpsyc.1990.01810180077011","article-title":"Specificity of serotonin reuptake inhibitors in the treatment of obsessive\u2013compulsive disorder: comparison of luvoxamine and desipramine","volume":"47","author":"Goodman","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00004850-199603000-00003","article-title":"Treatment of obsessive- compulsive disorder with fluvoxamine: a multi-centre, double-blind, placebo-controlled trial","volume":"11","author":"Goodman","year":"1996","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pcl.2004.11.004_bib58","first-page":"1543","article-title":"Fluvoxamine treatment of obsessive\u2013compulsive disorder","volume":"144","author":"Perse","year":"1988","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib59","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00004714-199702000-00002","article-title":"Long-term pharmacotherapy of obsessive\u2013compulsive disorder: a double-blind controlled study","volume":"17","author":"Mundo","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pcl.2004.11.004_bib60","series-title":"Diagnostic and statistical manual of mental disorders","year":"1994"},{"key":"10.1016\/j.pcl.2004.11.004_bib61","series-title":"Psychiatrist drugs","first-page":"53","article-title":"Antidepressant medication","author":"Liberman","year":"2000"},{"key":"10.1016\/j.pcl.2004.11.004_bib62","first-page":"1202","article-title":"The use of bethanechol chloride with tricyclic antidepressants","volume":"132","author":"Everett","year":"1976","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib63","first-page":"210","article-title":"Bethanecol chloride can reverse erectile and ejaculatory dysfunction induced by tricyclic antidepressants and mazindol: case report","volume":"47","author":"Yager","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib64","first-page":"272","article-title":"The newer antidepressant drugs and their cardiovascular effects","volume":"20","author":"Glassman","year":"1984","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pcl.2004.11.004_bib65","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0165-1781(86)90074-0","article-title":"Chronic imipramine treatment weight gain","volume":"17","author":"Fernstrom","year":"1986","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pcl.2004.11.004_bib66","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00006842-197911000-00004","article-title":"Changes in weight during treatment for depression","volume":"41","author":"Kupfer","year":"1979","journal-title":"Psychosom Med"},{"key":"10.1016\/j.pcl.2004.11.004_bib67","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0196-0644(86)80375-4","article-title":"Relative toxicity of cyclic antidepressants","volume":"15","author":"Wedin","year":"1986","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.pcl.2004.11.004_bib68","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0006-2952(96)00509-6","article-title":"Antidepressants and seizures: clinical anecdotes overshadow neuroscience","volume":"52","author":"Daily","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pcl.2004.11.004_bib69","first-page":"289","article-title":"Seizures associated with antidepressants: a review","volume":"54","author":"Rosenstein","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib70","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1176\/ajp.141.2.283","article-title":"A case of akinesia induced by amoxapine","volume":"141","author":"Gammon","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib71","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1176\/ajp.140.1.115","article-title":"Akathisia induced by amoxapine","volume":"140","author":"Ross","year":"1983","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib72","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1176\/ajp.141.5.704","article-title":"Case report of tardive dyskinesia and parkinsonism associated with amoxapine therapy","volume":"141","author":"Thornton","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib73","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/00006324-199512000-00006","article-title":"Medications used to prevent migraine headaches and their potential ocular adverse effects","volume":"72","author":"Doughty","year":"1995","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.pcl.2004.11.004_bib74","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.me.44.020193.002035","article-title":"Special aspects of neuropsychiatric illness I women: with a focus on depression","volume":"44","author":"Hamilton","year":"1993","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.pcl.2004.11.004_bib75","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1526-4610.1994.hed3401044.x","article-title":"Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine","volume":"34","author":"Manna","year":"1994","journal-title":"Headache"},{"key":"10.1016\/j.pcl.2004.11.004_bib76","first-page":"298","article-title":"Low-dose trazodone as a hypnotic in patients treated with MAOIs and other psychotropics: a pilot study","volume":"51","author":"Jacobsen","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib77","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00004714-198902000-00009","article-title":"Management of monoamine oxidase inhibitor-associated insomnia with trazodone","volume":"9","author":"Nierenberg","year":"1989","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pcl.2004.11.004_bib78","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00004850-199612000-00009","article-title":"Phasic craving for carbohydrate observed with citalopram","volume":"11","author":"Bouwer","year":"1996","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pcl.2004.11.004_bib79","first-page":"288","article-title":"Postmarketing surveillance by patient self-monitoring: preliminary data for sertraline versus fluoxetine","volume":"56","author":"Fisher","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib80","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00004850-199007000-00004","article-title":"Adverse interactions encountered when using trazodone to treat insomnia associated with fluoxetine","volume":"5","author":"Metz","year":"1990","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pcl.2004.11.004_bib81","series-title":"Textbook of clinical psychiatry","first-page":"1057","article-title":"Pharmacology and electro convulsive therapy","author":"Marangell","year":"2003"},{"key":"10.1016\/j.pcl.2004.11.004_bib82","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s001340050303","article-title":"Serotonin syndrome due to an overdose of moclobemide and clomipramine: a potentially life-threatening association","volume":"23","author":"Francois","year":"1997","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.pcl.2004.11.004_bib83","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/0960327197016001031","article-title":"Serotonin syndrome due to venlafaxine and maintenance tranylcypromine therapy","volume":"16","author":"Hodgman","year":"1997","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.pcl.2004.11.004_bib84","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/15563659709001196","article-title":"Venlafaxine induced serotonin syndrome occurring after abstinence from phenelzine for more than two weeks [letter]","volume":"35","author":"Kolecki","year":"1997","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.pcl.2004.11.004_bib85","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00004714-199310000-00003","article-title":"Possible monoamine oxidase inhibitor\u2013serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings","volume":"13","author":"Beasley","year":"1993","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pcl.2004.11.004_bib86","series-title":"Textbook of clinical psychiatry","first-page":"1059","article-title":"Pharmacology and electro convulsive therapy","author":"Marangell","year":"2003"},{"key":"10.1016\/j.pcl.2004.11.004_bib87","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/archpsyc.1984.01790180039005","article-title":"Phenelzine vs imipramine in atypical depression: a preliminary report","volume":"41","author":"Liebowitz","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib88","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archpsyc.1979.01780070027003","article-title":"Monoamine oxidase inhibitors: a review of antidepressant effectiveness","volume":"35","author":"Qitkin","year":"1979","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib89","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archpsyc.1980.01780220113013","article-title":"Phenelzine and amitriptyline in the treatment of depression: a comparison of present and past studies","volume":"37","author":"Ravaris","year":"1980","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib90","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0033-3182(85)72877-0","article-title":"A clinical overview of monoamine oxidase inhibitors","volume":"26","author":"Zisook","year":"1985","journal-title":"Psychosomatics"},{"key":"10.1016\/j.pcl.2004.11.004_bib91","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-2007-1014572","article-title":"High-dose tranylcypromine therapy for refractory depression","volume":"22","author":"Amsterdam","year":"1989","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib92","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archpsyc.1980.01780180069007","article-title":"Amitriptyline once daily versus three times daily in depressed outpatients","volume":"37","author":"Weise","year":"1980","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pcl.2004.11.004_bib93","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00004714-199610000-00003","article-title":"Serotonin reuptake inhibitor withdrawal","volume":"16","author":"Coupland","year":"1996","journal-title":"J Clin Psychopharmacol"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395504001592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395504001592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T23:59:53Z","timestamp":1548547193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395504001592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0031395504001592"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2004.11.004","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}